SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul S. who wrote (293)3/19/1998 8:17:00 AM
From: F. Jay Abella, III  Read Replies (1) of 1185
 
All of the above:

First off, we are all going to do exceptionally well holding NRT long.

I think TSE listing is imminent. The question is; who bought all the shares between 0.80 and 1.60? The answer to this will reveal whether or not more accumulation will be coming. I will try to find out.

Also remember that CCM has warrants to purchase 810k more NRT shares at $2.00 before 29Sept98. This to me is a foregone conclusion. However, there is a distinct possibility that the subscribers to the Feb97 financing could take NRT down to near $1.00 after a CCM exercise at $2.00 before their Feb97 warrants expire in Feb 99 (very risky). They may have already exercised them, but I doubt it.

I hope the stock price is not as "predictable" as I make it out to be (and hopefully we'll have some big news in the next year to drive value). But, if "predictability" is in the cards, I see Mr. Rieder's first task to get NRT listed on the AMEX as well as, or instead of, the TSE.

FJA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News